Vilin Bio Med (NSE:VILINBIO) Interest Expense : ₹-3.78 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vilin Bio Med's interest expense for the six months ended in Sep. 2023 was ₹ -3.78 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-3.78 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vilin Bio Med's Operating Income for the six months ended in Sep. 2023 was ₹ 13.13 Mil. Vilin Bio Med's Interest Expense for the six months ended in Sep. 2023 was ₹ -3.78 Mil. Vilin Bio Med's Interest Coverage for the quarter that ended in Sep. 2023 was 3.48. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vilin Bio Med Interest Expense Historical Data

The historical data trend for Vilin Bio Med's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Interest Expense Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Interest Expense

-3.80

-4.15

-4.95

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Interest Expense	-	-	-	-3.20	-3.78

Vilin Bio Med Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-3.78 Mil.

Vilin Bio Med (NSE:VILINBIO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vilin Bio Med's Interest Expense for the six months ended in Sep. 2023 was ₹-3.78 Mil. Its Operating Income for the six months ended in Sep. 2023 was ₹13.13 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was ₹2.53 Mil.

Vilin Bio Med's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2023 )	/	Interest Expense (Q: Sep. 2023 )
	=	-1	*	13.127	/	-3.776
	=	3.48

The higher the ratio, the stronger the company's financial strength is.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines